KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Current Leases (2017 - 2026)

Cardlytics filings provide 9 years of Current Leases readings, the most recent being $1.5 million for Q1 2026.

  • Quarterly Current Leases fell 11.52% to $1.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Mar 2026, down 11.52% year-over-year, with the annual reading at $1.4 million for FY2025, 28.99% down from the prior year.
  • Current Leases hit $1.5 million in Q1 2026 for Cardlytics, up from $1.4 million in the prior quarter.
  • Across five years, Current Leases topped out at $6.2 million in Q1 2022 and bottomed at $1.2 million in Q2 2025.
  • Average Current Leases over 5 years is $3.0 million, with a median of $2.2 million recorded in 2023.
  • The largest annual shift saw Current Leases plummeted 63.14% in 2023 before it rose 5.21% in 2024.
  • Cardlytics' Current Leases stood at $4.9 million in 2022, then crashed by 56.68% to $2.1 million in 2023, then fell by 4.8% to $2.0 million in 2024, then fell by 28.99% to $1.4 million in 2025, then increased by 2.02% to $1.5 million in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Current Leases are $1.5 million (Q1 2026), $1.4 million (Q4 2025), and $1.6 million (Q3 2025).